tiprankstipranks
Advertisement
Advertisement

Earth Science Tech Reports Strong Q3 2026 Financial Performance

Story Highlights
  • Earth Science Tech reported a 14% revenue rise, margin expansion, and a 341% net income jump in Q3 2026.
  • Cash-flow-positive units, share repurchases, and geographic expansion strengthened Earth Science Tech’s financial and strategic position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Earth Science Tech Reports Strong Q3 2026 Financial Performance

Claim 30% Off TipRanks

Earth Science Tech ( (ETST) ) has shared an update.

Earth Science Tech, Inc., a diversified health and wellness holding company with compounding pharmacies, telemedicine platforms, healthcare facilities, and ancillary real estate and consumer brands, reported strong third fiscal quarter 2026 results for the period ended Dec. 31, 2025, highlighted by rising revenue and profitability. Revenue rose 14.1% year over year to $8.4 million, gross margin expanded to 76.3%, and net income jumped 341% to $910,000, while its Peaks telemedicine platform surpassed $2 million in revenue in under a year, the company generated positive operating cash flow, maintained a debt-free balance sheet, and continued share repurchases that reduced its share count by 3.6%, collectively signaling improved operating leverage and a stronger financial position for stakeholders.

Management noted that multiple operating units are now cash-flow positive despite seasonal and macro headwinds, with total assets up 14.5% since March 31, 2025 and working capital turning positive even as cash declined due to inventory investments to support higher sales. The company repurchased and retired 3.7 million shares over nine months, underscoring confidence in its portfolio strategy and earnings trajectory, while geographic expansion with up to 10 additional state licenses pending positions its pharmacy and telemedicine operations for further scale and margin gains.

The most recent analyst rating on (ETST) stock is a Buy with a $0.15 price target. To see the full list of analyst forecasts on Earth Science Tech stock, see the ETST Stock Forecast page.

Spark’s Take on ETST Stock

According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.

The score is driven primarily by improved financial performance (strong margins, profitability, low leverage, and positive free cash flow), tempered by weak technicals (price below major moving averages and negative MACD). Valuation is supportive with a modest P/E, while recent corporate events are positive but largely reputational/communications-focused.

To see Spark’s full report on ETST stock, click here.

More about Earth Science Tech

Earth Science Tech, Inc. is a diversified holding company in the health and wellness sector, operating a vertically integrated portfolio of compounding pharmacies, telemedicine platforms, and healthcare facilities across a growing number of U.S. states. Its assets include RxCompoundStore.com and Mister Meds for sterile and non-sterile medications, Peaks Curative and DOConsultation.com for telemedicine and personalized care, Las Villas Health Care for clinical support, as well as Avenvi in real estate and asset management and an 80% stake in MagneChef, a consumer brand for innovative kitchen products.

Average Trading Volume: 56,202

Technical Sentiment Signal: Sell

Current Market Cap: $38.01M

Learn more about ETST stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1